Doctor of Optometry Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Julia Kitchens

Optometrist St Johnsbury, VT Doctor of Optometry

NPI 1245894229 CMS profile 6867746

468 Hospital Dr, St Johnsbury, VT 05819

Open in the dashboard

General payments

$247

10 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Julia Kitchens of St Johnsbury, VT is reported in the CMS Open Payments database as having received $247 across 10 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 29th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $18 1
2021 General $125 5
2020 General $45 2
2019 General $58 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Julia Kitchens
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Julia Kitchens were reported at $0. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Julia Kitchens Optometrist median Middle half National median
2019 $58 $159 $67–$371 $163
2020 $45 $72 $29–$165 $114
2021 $125 $125 $46–$292 $132
2022 $0 $162 $66–$374 $149
2023 $18 $177 $72–$406 $160
2024 $0 $188 $77–$427 $164
2025 $0 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Bausch & Lomb, a division of Bausch Health US, LLC $120 5 payments
  2. CooperVision Inc. $61 2 payments
  3. Sun Pharmaceutical Industries Inc. $28 1 payment
  4. Novartis Pharmaceuticals Corporation $23 1 payment
  5. Allergan Inc. $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $247 10 payments
Products named General payments · program years 2019–2023
  1. ULTRA $75 3 payments
  2. Multiple Brands Contact Lens $43 1 payment
  3. BTOD $34 2 payments
  4. Cequa $28 1 payment
  5. XIIDRA $23 1 payment
  6. INFUSE $23 1 payment
  7. MyDay Contact Lens $18 1 payment
  8. RESTASIS MULTIDOSE $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

454

Median for Optometry: 120

Drug cost

$92,325

Median for Optometry: $8,864

Branded share of claims

37.9%

Median for Optometry: 24.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Restasis Cyclosporine Brand 46 $63,719
Lumigan Bimatoprost Brand 37 $20,220
Fluorometholone Generic 38 $2,892
Latanoprost Generic 133 $1,973
Prednisolone Acetate Generic 35 $1,016
Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat Brand 49 $797
Timolol Maleate Generic 51 $581
Tobramycin-Dexamethasone Tobramycin/Dexamethasone Brand 16 $572
Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha Brand 24 $284
Brimonidine Tartrate Generic 25 $270

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 27,653 Part D prescribers listed as Optometry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$82,947

Medicare's payments for the services billed

Medicare patients

635

Average age 74

Services billed

1,614

369 women, 266 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 60%
Arthritis 36%
Diabetes 27%
Depression 17%
Ischemic heart disease 15%
Atrial fibrillation 14%
Chronic kidney disease 13%
Osteoporosis 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

10 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Vermont

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record